We welcome the opportunity to work with leaders across Europe to ensure that patient needs, evidence and lived experience remain central to policy and practice.

#EuropeanCancerSummit2025 #PatientAdvocacy #KidneyCancer @europeancancer.bsky.social (2/2)

This World Cancer Declaration provides a framework for coordinated action across countries to integrate cancer control into health and development agendas. www.uicc.org/resources/wo... (3/3)

Together with 130 UICC members and partners, IKCC outlines a global commitment to reduce cancer mortality and improve equitable access to cancer prevention, diagnosis, treatment, and care. (2/3)

Together, we’re working to strengthen global collaboration and accelerate progress against the global cancer burden. #WCLS2025 (2/2)

She is keen to leverage this knowledge to support IKCC’s efforts in advocacy, stakeholder engagement and resource mobilisation globally and especially the Asia Pacific region.

Find the bios of all Board members here: ikcc.org/about-ikcc/b... #KidneyCancer (10/10)

She brings 40 years of leadership and project management experience related to healthcare, sustainable financing and social and environmental issues. (9/10)

Finally, following the most recent call for nominations, we are pleased to announce that Carmen Vallejo Auste, the CEO of Cancer Warriors in the Philippines, has joined the Board of Directors. (8/10)

His extensive experience in governance, particularly within the Dutch regulatory framework where IKCC is legally based, adds significant value to the IKCC Board. Anne Wilson has now moved into a one-year term as Past Secretary/Treasurer. (7/10)

Bryan Lewis (US) will serve as past-Vice-Chair for one year.

Dr Bart van Goudoever (NL) is now Secretary / Treasurer. He has held financial leadership positions on many boards across various social service and health-related sectors. (6/10)

The combination of her professional experience as an advocacy and lobbying specialist coupled with her personal experience as a caregiver to her father and grandfather who were both diagnosed with kidney cancer, brings a unique and valuable perspective to the organisation. (5/10)

Claudia Ungarelli (IT) has become Vice-Chair of the Board of Directors. Claudia first joined the IKCC Board in 2023. (4/10)

Eric has been a champion of evidence-based activities and advocacy. He has been involved in IKCC’s Clinical Leadership Development Program and was instrumental in expanding MAB membership globally. Dr Michael Jewett has now moved into the position of Immediate Past Chair. (3/10)

After serving as a Board member since 2017 and Chair of IKCC’s Medical Advisory Board (MAB) for the past two years, Dr Eric Jonasch (US) is now Board Chair of IKCC’s Board of Directors. (2/10)

Learn more at www.kidneycancer.org/2025-ikcsna-...

(Photo: Dr Michael Jewett and Dr Eric Jonasch)

#KidneyCancer (2/2)

The application deadline is 18 November 2025.

Learn more: www.aacr.org/professional... #AACR26 (3/3)

As a global organisation, IKCC is committed to research and knowledge transfer among those focused on improving kidney cancer treatment and care and we are proud to support this initiative and are committed to supporting opportunities for researchers from lower- and middle-income countries. (2/3)